EVALUATION OF LIPID-LOWERING THERAPY IN PATIENTS WITH DEFINITE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN LODZ

被引:0
|
作者
Gorzelak-Pabis, P. [1 ]
Pawlos, A. [2 ]
Staciwa, Z. [1 ]
Krulikowska, A. [1 ]
Broncel, M. [1 ]
机构
[1] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lab Tissue Immunopharmacol, Lodz, Poland
[2] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lab Tissue Immunopharmacol, Lodz, Poland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP409
引用
收藏
页码:E225 / E226
页数:2
相关论文
共 50 条
  • [1] ADHERENCE TO LIPID-LOWERING THERAPY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V.
    Kuznetsova, T.
    ATHEROSCLEROSIS, 2018, 275 : E174 - E175
  • [2] ADHERENCE AND EFFICIENCY OF LIPID-LOWERING THERAPY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN RUSSIA
    Ezhov, M. V.
    Tmoyan, N. A.
    Rozhkova, T. A.
    Duplyakov, D. V.
    Salchenko, V. A.
    Kachkovskii, M. A.
    Shaposhnik, I. I.
    Genkel, V. V.
    Gurevich, V. S.
    Urazgildeeva, S. A.
    Tregubov, A. V.
    Muzalevskaya, M. V.
    Bazhan, S. S.
    Timoshenko, O. V.
    Urvanceva, I. A.
    Kozhokar, K. G.
    Sokolov, A. A.
    Tishko, V. V.
    Boeva, O. I.
    Bolotova, E. V.
    Namitokov, A. M.
    Kushnareva, Y. B.
    Kuznetsova, T. Y.
    Korneva, V. A.
    Bogdanov, D. Y.
    Chichina, E. E.
    Soloviev, V. M.
    Ershova, A. I.
    Meshkov, A. N.
    Makogonenko, V. I.
    Galyavich, A. S.
    Sadykova, D. I.
    Pomogaybo, B. V.
    Barbarash, O. L.
    Kashtalap, V. V.
    Shutemova, E. A.
    Isaeva, I. G.
    Khokhlov, R. A.
    Oleynikov, V. E.
    Avdeeva, I. V.
    Chubykina, U. V.
    Bliznyuk, S. A.
    Alieva, A. S.
    Ovsyannikova, V. V.
    Furmenko, G. I.
    Chernykh, T. M.
    Abashina, O. E.
    Djanibekova, A. R.
    Slastnikova, E. S.
    Galimova, L. F.
    ATHEROSCLEROSIS, 2020, 315 : E43 - E43
  • [3] TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH LIPID-LOWERING DRUGS
    ILLINGWORTH, DR
    BACON, S
    ARTERIOSCLEROSIS, 1989, 9 (01): : I121 - I134
  • [4] LIPID LOWERING THERAPY WITH STATINS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V. A.
    Kuznetsova, T. Yu
    Tihova, G. P.
    KARDIOLOGIYA, 2019, 59 (03) : 27 - 35
  • [5] GENETIC MUTATIONS AND LIPID-LOWERING RESPONSE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kim, H.
    Lee, S. H.
    ATHEROSCLEROSIS, 2020, 315 : E97 - E98
  • [6] Aortic Valvular Disease in Elderly Subjects with Heterozygous Familial Hypercholesterolemia: Impact of Lipid-Lowering Therapy
    Marco-Benedi, Victoria
    Laclaustra, Martin
    Casado-Dominguez, Juan M.
    Villa-Pobo, Rosa
    Mateo-Gallego, Rocio
    Sanchez-Hernandez, Rosa M.
    Blanco Nuez, Marta
    Ortega-Martinez de Victoria, Emilio
    Sitges, Marta
    Pedro-Botet, Juan
    Puzo, Jose
    Villarroel, Teresa
    Civeira, Fernando
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [7] Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
    Galema-Boers, Annette M.
    Lenzen, Mattie J.
    Engelkes, Sophie R.
    Sijbrands, Eric J.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 409 - 416
  • [8] Regression of tendon xanthomata after lipid lowering therapy in patients with heterozygous familial hypercholesterolemia
    Kolovou, G
    Hatzaki, A
    Kafaltis, N
    Hoursalas, J
    Adamopoulou, E
    Mastorakou, I
    Aggelakas, S
    Cokkinos, DV
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 57 - 57
  • [9] Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia
    Capra, Maria Elena
    Biasucci, Giacomo
    Banderali, Giuseppe
    Vania, Andrea
    Pederiva, Cristina
    CHILDREN-BASEL, 2024, 11 (02):
  • [10] Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia
    Ferrari, Filipe
    Martins, Vitor M.
    Rocha, Viviane Z.
    Santos, Raul D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (04) : 483 - 495